Inactive Instrument
CUSPIS CAP L Stock Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 301M 210M 184M 170M 157M 295M 20.19B 2.02B 794M 9.89B 789M 772M 34.04B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 301M 210M 184M 170M 157M 295M 20.19B 2.02B 794M 9.89B 789M 772M 34.04B | EV / Sales 2026 * |
107x | EV / Sales 2027 * | 4.12x |
| Free-Float |
86.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 2016-08-09 |
Joshua George
DFI | Director of Finance/CFO | - | 2024-04-07 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 2026-04-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 2016-08-09 |
Robert Galyen
BRD | Director/Board Member | - | 2023-06-30 |
Jack Perkowski
CHM | Chairman | 76 | 2023-10-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 210M | ||
| -4.15% | -10.22% | +108.65% | +25.72% | 5.77B | ||
| +1.83% | -2.40% | -31.19% | -47.64% | 2.33B | ||
| +1.25% | -8.93% | +48.63% | +151.10% | 1.13B | ||
| +5.86% | -11.85% | +109.02% | +105.96% | 967M | ||
| +1.21% | +1.83% | +19.86% | +2.18% | 585M | ||
| +0.33% | +2.87% | -26.59% | -53.65% | 542M | ||
| +2.97% | -3.14% | -20.13% | -11.05% | 285M | ||
| +2.67% | -2.94% | -46.40% | +4.76% | 232M | ||
| -0.67% | -3.87% | -35.78% | -52.55% | 192M | ||
| Average | +2.49% | -3.00% | +14.01% | +13.87% | 1.34B | |
| Weighted average by Cap. | -0.63% | -4.32% | +57.23% | +22.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.96M 1.71M 1.58M 1.46M 2.75M 188M 18.85M 7.4M 92.03M 7.35M 7.19M 317M | 73M 51.01M 44.58M 41.21M 38.07M 71.7M 4.9B 491M 193M 2.4B 192M 187M 8.26B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















